Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, plans to announce the results of a Phase 2b trial for Empatic(TM) on Wednesday, September 30, 2009 before the markets open.

While pharmaceuticals have always had a vital impact on patients’ outcomes and improved quality of life, they also have played a large role in the growing expenditures of healthcare. Increased spending on pharmaceuticals outpaced every other category...

I’ve been preaching about the misuse of antibiotics for years, and the public at large is finally getting the message. “Antibiotic resistance and superbugs such as MRSA,” I’d say with the utmost conviction, “is due to so many unnecessary prescriptions...

Note: There is a poll embedded within this post, please visit the site to participate in this post's poll. Last weeks Did You Know: Which of the following antacids were developed in 1928, in the basement laboratory of St. Louis Pharmacist Jim Howe,...

As the end of the year fast approaches, it’s time to look at your flexible spending account (FSA). These accounts tend to be “use it or lose it”, as it is wise to determine if you have a surplus of funds and how to utilize them so they aren’t lost....

Richard Fan is a practicing emergency/trauma physician assistant in a busy Southern California ER, and an medical officer on the federal disaster response team, DMAT CA-1. Mr. Fan teaches a free video e-course on emergency suture techniques. Learn a...